Pramlintide: A new tool in diabetes management
- PMID: 17076994
- DOI: 10.1007/s11892-006-0004-0
Pramlintide: A new tool in diabetes management
Abstract
The amylin analogue pramlintide acts in concert with insulin to regulate glucose metabolism. It reduces postprandial hyperglycemia by suppressing postprandial glucagon secretion, regulating gastric emptying, and reducing food intake. In clinical use, pramlintide reduces postprandial glycemic excursions and improves A(1c) without the weight gain and increased risk of hypoglycemia typically seen with intensification of diabetes therapy.
Similar articles
-
Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.Clin Ther. 2007 Apr;29(4):535-62. doi: 10.1016/j.clinthera.2007.04.005. Clin Ther. 2007. PMID: 17617279 Review.
-
Pramlintide in the treatment of diabetes mellitus.BioDrugs. 2008;22(6):375-86. doi: 10.2165/0063030-200822060-00004. BioDrugs. 2008. PMID: 18998755 Review.
-
Pramlintide for the treatment of diabetes mellitus.Ann Pharmacother. 2003 Jul-Aug;37(7-8):1082-9. doi: 10.1345/aph.1C387. Ann Pharmacother. 2003. PMID: 12841822 Review.
-
Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.Clin Ther. 2005 Oct;27(10):1500-12. doi: 10.1016/j.clinthera.2005.10.009. Clin Ther. 2005. PMID: 16330288 Review.
-
The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes.Diabetes. 2005 Apr;54(4):1100-7. doi: 10.2337/diabetes.54.4.1100. Diabetes. 2005. PMID: 15793249 Clinical Trial.
Cited by
-
Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.Diabetes Technol Ther. 2008 Oct;10(5):391-6. doi: 10.1089/dia.2007.0295. Diabetes Technol Ther. 2008. PMID: 18715216 Free PMC article.
-
Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk.Vasc Health Risk Manag. 2008;4(2):355-62. doi: 10.2147/vhrm.s1978. Vasc Health Risk Manag. 2008. PMID: 18561511 Free PMC article. Review.
-
Weight-centric treatment of type 2 diabetes mellitus.Obes Pillars. 2022 Nov 24;4:100045. doi: 10.1016/j.obpill.2022.100045. eCollection 2022 Dec. Obes Pillars. 2022. PMID: 37990663 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical